STARTRK-2
Hoffmann-La Roche
Hoffmann-La Roche
M.D. Anderson Cancer Center
Endeavor Biomedicines, Inc.
Melanoma Institute Australia
M.D. Anderson Cancer Center
Mayo Clinic
M.D. Anderson Cancer Center
Melanoma Institute Australia
National Cancer Institute (NCI)
Yale University
Sutter Health
M.D. Anderson Cancer Center
Day One Biopharmaceuticals, Inc.
Grupo Español Multidisciplinar de Melanoma
Stanford University
Yale University
Grupo Español Multidisciplinar de Melanoma
Children's National Research Institute
Dana-Farber Cancer Institute
Centre hospitalier de l'Université de Montréal (CHUM)
UNICANCER
University Medical Center Groningen
Memorial Sloan Kettering Cancer Center
Technische Universität Dresden
Hoffmann-La Roche
Herlev Hospital
Eastern Cooperative Oncology Group
Pfizer
Grupo Español Multidisciplinar de Melanoma
Duke University
Canadian Cancer Trials Group
University of Michigan Rogel Cancer Center
National Institutes of Health Clinical Center (CC)
Yale University
DEKK-TEC, Inc.
Cambridge University Hospitals NHS Foundation Trust
Center Eugene Marquis
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Novartis
GlaxoSmithKline
Alliance for Clinical Trials in Oncology
Memorial Sloan Kettering Cancer Center
University Hospital, Lille
GE Healthcare
Pharmacyclics LLC.
National Cancer Institute (NCI)
SWOG Cancer Research Network
National Cancer Institute (NCI)